II. Indications

III. Mechanism

  1. See Antibiotic Chemotherapy
  2. Idarubicin is a anthracycline Aminoglycoside antineoplastic
    1. Semisynthetic 4-demethoxy analog of Daunorubicin
  3. Idarubicin inserts between adjacent DNA base pairs
    1. Blocks DNA Transcription by RNA Polymerase
  4. Idarubicin also inhibits Topoisomerase 2
    1. Inhibits normal Nucleotide strand ligation during DNA Replication
  5. Idarubicin is highly lipophilic
    1. Allows Idarubicin to more easily cross cell membranes (more than other Anthracyclines)

IV. Medications

  1. Idarubicin IV Solution: 1 mg/ml in 10 and 20 ml vials

V. Dosing

  1. See other references for disease specific dosing protocols

VI. Adverse Effects

  1. Severe skin and soft tissue necrosis on extravasation
    1. Idarubicin is a strong Vesicant (causes Blistering)
  2. Cardiotoxicity (esp. children)
    1. Risk of Congestive Heart Failure (esp. with multiple doses)
  3. Myelosuppression
  4. Hyperuricemia
  5. Alopecia

VII. Safety

  1. Avoid in Lactation
  2. Avoid in pregnancy (all trimesters)
    1. Use reliable Contraception
  3. Monitoring
    1. Complete Blood Count
    2. Liver Function Tests
    3. Renal Function Tests
    4. Serum Uric Acid
    5. Echocardiogram with ejection fraction

Images: Related links to external sites (from Bing)

Related Studies

Ontology: Idarubicin (C0020789)

Definition (MSH) An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.
Definition (NCI_NCI-GLOSS) An anticancer drug that belongs to the family of drugs called antitumor antibiotics.
Definition (NCI) A semisynthetic 4-demethoxy analogue of the antineoplastic anthracycline antibiotic daunorubicin. Idarubicin intercalates into DNA and interferes with the activity of topoisomerase II, thereby inhibiting DNA replication, RNA transcription and protein synthesis. Due to its high lipophilicity, idarubicin penetrates cell membranes more efficiently than other anthracycline antibiotic compounds.
Definition (PDQ) A semisynthetic anthracycline antineoplastic antibiotic derived from daunorubicin. Idarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. Due to its high lipophilicity, idarubicin penetrates cell membranes better than other anthracycline antibiotics. Idarubicin hydrochloride is the therapeutic form of this drug. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39753&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39753&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C562" NCI Thesaurus)
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D015255
SnomedCT 108786002, 372539000
English 4 Demethoxydaunorubicin, 4 Desmethoxydaunorubicin, 4-Demethoxydaunorubicin, 4-Desmethoxydaunorubicin, 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-, (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-hexopyranoside, (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione, 4DMDR, 4-Demethoxydaunomycin, DEMETHOXYDAUNORUBICIN 04, Idarubicin [Chemical/Ingredient], IDArubicin, idarubicin, IDARUBICIN, Idarubicin (product), Idarubicin (substance), 4-demethoxydaunorubicin, DMDR, IDA, 4-DMDR, Idarubicin
Swedish Idarubicin
Czech idarubicin
Finnish Idarubisiini
Russian 4-DEMETOKSIDAUNORUBITSIN, IDARUBITSIN, 4-ДЕМЕТОКСИДАУНОРУБИЦИН, ИДАРУБИЦИН
Japanese イダルビシン, 4-デメトキシダウノルビシン
German DEMETHOXYDAUNORUBICIN 04, 4-Demethoxydaunorubicin, Idarubicin
Polish Idarubicyna
Spanish idarrubicina (producto), idarrubicina (sustancia), idarrubicina, 4-Demetoxidaunorrubicina, Idarrubicina
French Idarubicine
Italian Idarubicina
Portuguese 4-Demetoxidaunorubicina, Idarubicina